Research analysts at Craig Hallum began coverage on shares of Tivity Health (NASDAQ:TVTY) in a note issued to investors on Thursday, The Fly reports. The firm set a “buy” rating and a $30.00 price target on the stock. Craig Hallum’s price target would suggest a potential upside of 48.15% from the company’s previous close.

Several other equities analysts have also recently issued reports on the company. BidaskClub raised Tivity Health from a “sell” rating to a “hold” rating in a research note on Tuesday. Zacks Investment Research raised Tivity Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 21st. Jefferies Financial Group reduced their price target on Tivity Health to $29.00 and set a “buy” rating on the stock in a research note on Wednesday, February 20th. Piper Jaffray Companies reduced their price target on Tivity Health to $29.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 20th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $40.00 price target on shares of Tivity Health in a research note on Wednesday, February 20th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eight have given a buy rating to the company. Tivity Health currently has an average rating of “Buy” and a consensus price target of $32.00.

TVTY opened at $20.25 on Thursday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.96 and a current ratio of 0.96. Tivity Health has a 52-week low of $16.25 and a 52-week high of $41.46. The company has a market cap of $811.16 million, a PE ratio of 8.65, a price-to-earnings-growth ratio of 0.82 and a beta of 1.01.

Tivity Health (NASDAQ:TVTY) last posted its earnings results on Tuesday, February 19th. The company reported $0.73 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.57 by $0.16. Tivity Health had a return on equity of 30.19% and a net margin of 16.30%. The firm had revenue of $153.04 million for the quarter, compared to analysts’ expectations of $153.66 million. As a group, equities analysts anticipate that Tivity Health will post 2.33 EPS for the current year.

In other Tivity Health news, Director Bradley S. Karro purchased 2,900 shares of the stock in a transaction dated Friday, March 22nd. The shares were purchased at an average cost of $16.54 per share, with a total value of $47,966.00. Following the completion of the acquisition, the director now directly owns 24,696 shares in the company, valued at approximately $408,471.84. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Sara Finley purchased 2,000 shares of the stock in a transaction dated Wednesday, March 20th. The shares were acquired at an average cost of $17.25 per share, for a total transaction of $34,500.00. The disclosure for this purchase can be found here. Insiders own 0.73% of the company’s stock.

Several large investors have recently made changes to their positions in TVTY. State of Alaska Department of Revenue lifted its holdings in Tivity Health by 16.3% in the first quarter. State of Alaska Department of Revenue now owns 15,917 shares of the company’s stock valued at $279,000 after acquiring an additional 2,226 shares during the period. Tibra Equities Europe Ltd bought a new position in Tivity Health in the first quarter valued at about $483,000. Geode Capital Management LLC lifted its holdings in Tivity Health by 16.5% in the fourth quarter. Geode Capital Management LLC now owns 686,669 shares of the company’s stock valued at $17,035,000 after acquiring an additional 97,030 shares during the period. Norges Bank bought a new position in Tivity Health in the fourth quarter valued at about $12,171,000. Finally, Dimensional Fund Advisors LP lifted its holdings in Tivity Health by 1.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,655,265 shares of the company’s stock valued at $41,067,000 after acquiring an additional 29,384 shares during the period.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Recommended Story: Day Trading

The Fly

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.